Zhejiang Huahai Pharmaceutical Co., Ltd.

XSSC:600521 Stock Report

Market Cap: CN¥25.2b

Zhejiang Huahai Pharmaceutical Future Growth

Future criteria checks 3/6

Zhejiang Huahai Pharmaceutical is forecast to grow earnings and revenue by 22% and 15.5% per annum respectively. EPS is expected to grow by 22% per annum. Return on equity is forecast to be 17.4% in 3 years.

Key information

22.0%

Earnings growth rate

22.0%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth rate15.5%
Future return on equity17.4%
Analyst coverage

Low

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600521 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202613,2201,897N/A3,6502
12/31/202511,7171,624N/A1,0673
12/31/20249,9851,324N/A1,9413
9/30/20249,3491,1401,1712,643N/A
6/30/20249,1431,0101,1732,624N/A
3/31/20248,7489281,1392,696N/A
12/31/20238,3098306252,217N/A
9/30/20238,6351,0951162,096N/A
6/30/20238,7361,169-5311,643N/A
3/31/20238,5521,203-7721,515N/A
12/31/20228,2661,168-1,0741,243N/A
9/30/20227,884692-1,482857N/A
6/30/20227,432540-1,6481,015N/A
3/31/20226,919370-1,514975N/A
12/31/20216,644488-1,496938N/A
9/30/20216,212679-9941,068N/A
6/30/20216,215867-2851,341N/A
3/31/20216,412964-2821,265N/A
12/31/20206,4859302791,555N/A
9/30/20206,2478985461,670N/A
6/30/20206,0418138581,774N/A
3/31/20205,7606551,0541,877N/A
12/31/20195,3885709601,754N/A
9/30/20195,2633643911,340N/A
6/30/20195,209213-280740N/A
3/31/20195,05581-538560N/A
12/31/20185,095108-1,05768N/A
9/30/20185,335409-630506N/A
6/30/20185,190573N/A644N/A
3/31/20185,112661N/A518N/A
12/31/20175,002639N/A646N/A
9/30/20174,680601N/A222N/A
6/30/20174,460537N/A231N/A
3/31/20174,254519N/A306N/A
12/31/20164,093501N/A433N/A
9/30/20164,001492N/A453N/A
6/30/20163,848466N/A325N/A
3/31/20163,738464N/A238N/A
12/31/20153,500442N/A195N/A
9/30/20153,201399N/A262N/A
6/30/20153,071372N/A262N/A
3/31/20152,793313N/A258N/A
12/31/20142,585266N/A329N/A
9/30/20142,406277N/A217N/A
6/30/20142,220265N/A419N/A
3/31/20142,224310N/A433N/A
12/31/20132,296359N/A490N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600521's forecast earnings growth (22% per year) is above the savings rate (2.8%).

Earnings vs Market: 600521's earnings (22% per year) are forecast to grow slower than the CN market (26.3% per year).

High Growth Earnings: 600521's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600521's revenue (15.5% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 600521's revenue (15.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600521's Return on Equity is forecast to be low in 3 years time (17.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y